Salbair Neb 1.25 mg Transpules is a specialized inhalation therapy designed for patients suffering from chronic obstructive pulmonary disease (COPD). This formulation combines two active ingredients: Levosalbutamol and Ipratropium, which work synergistically to provide effective relief from respiratory distress. Salbair Neb 1.25 mg Transpules is classified as a bronchodilator and anticholinergic medication, making it a vital option in the therapeutic category of respiratory treatments. The primary purpose of Salbair Neb 1.25 mg Transpules is to relax the muscles in the airways, thereby widening them and facilitating easier breathing for individuals with COPD. The unique composition of Salbair Neb 1.25 mg Transpules ensures that patients receive a controlled dose of medication directly to the lungs, maximizing its efficacy while minimizing systemic side effects. This targeted delivery system is crucial for managing chronic respiratory conditions effectively. Salbair Neb 1.25 mg Transpules is particularly beneficial for patients who experience frequent episodes of breathlessness and require a reliable solution to manage their symptoms. By utilizing Salbair Neb 1.25 mg Transpules, patients can achieve better control over their condition, leading to improved quality of life and enhanced daily functioning. The formulation is designed for inhalation only, ensuring that the active ingredients reach the site of action quickly and efficiently. With its dual-action mechanism, Salbair Neb 1.25 mg Transpules not only alleviates symptoms but also helps prevent exacerbations associated with COPD, making it an essential part of a comprehensive treatment plan. Overall, Salbair Neb 1.25 mg Transpules represents a significant advancement in the management of chronic respiratory diseases, providing patients with the relief they need to breathe easier and live better.
This formulation combines Levosalbutamol and Ipratropium for enhanced bronchodilation.
Salbair Neb 1.25 mg Transpules helps to relax airway muscles, making breathing easier.
Patients using Salbair Neb 1.25 mg Transpules may experience fewer exacerbations of their respiratory condition.
Salbair Neb 1.25 mg Transpules is suitable for long-term management of COPD symptoms.
This therapy can improve overall lung function in patients with chronic respiratory issues.
Salbair Neb 1.25 mg Transpules is designed for inhalation, ensuring rapid action at the site of need.
Using Salbair Neb 1.25 mg Transpules can lead to improved quality of life for COPD patients.
Salbair Neb 1.25 mg Transpules may reduce the frequency of rescue inhaler use.
This medication is beneficial for patients who struggle with breathlessness during daily activities.
Salbair Neb 1.25 mg Transpules can help manage nighttime symptoms associated with COPD.
Patients may find that Salbair Neb 1.25 mg Transpules aids in reducing coughing episodes.
Salbair Neb 1.25 mg Transpules supports better oxygenation by widening air passages.
This therapy can be integrated into a comprehensive COPD management plan.
Salbair Neb 1.25 mg Transpules is often recommended for use alongside other COPD medications.
How Salbair Neb 1.25 mg Transpules works
Salbair Neb 1.25 mg Transpules works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
Levosalbutamol: A selective beta-2 adrenergic agonist that relaxes bronchial smooth muscles, leading to bronchodilation.
Ipratropium: An anticholinergic agent that inhibits bronchoconstriction by blocking acetylcholine receptors in the airways.
Together, these ingredients help widen the airways, making it easier for air to flow in and out of the lungs.
The inhalation route allows for direct delivery to the lungs, enhancing the therapeutic effect while minimizing systemic absorption.
Salbair Neb 1.25 mg Transpules provides quick relief from acute symptoms and helps maintain long-term control over chronic respiratory conditions.
This combination therapy reduces airway inflammation and mucus secretion, further improving breathing efficiency.
How to use Salbair Neb 1.25 mg Transpules
Salbair Neb 1.25 mg Transpules should be administered using a nebulizer for optimal delivery.
The recommended dosage is typically one nebulization (2.5 ml) as prescribed by a healthcare professional.
Frequency of use may vary; generally, it is advised to use Salbair Neb 1.25 mg Transpules every 6 to 8 hours as needed.
Patients should follow their doctor's instructions regarding the timing and frequency of doses.
The duration of treatment with Salbair Neb 1.25 mg Transpules should be determined by a healthcare provider based on individual patient needs.
It is important to rinse the mouth after each use to prevent dryness and potential fungal infections.
Patients should not swallow the solution; it is intended solely for inhalation.
Initial doses should be taken under medical supervision to monitor for any adverse reactions.
Lifestyle Advice
Maintain good hydration by drinking plenty of fluids to help keep airways moist while using Salbair Neb 1.25 mg Transpules.
Avoid exposure to smoke and pollutants that can aggravate respiratory conditions.
Incorporate regular physical activity as tolerated to improve lung function and overall health.
Practice good oral hygiene to minimize dry mouth effects associated with Salbair Neb 1.25 mg Transpules.
Consider using a humidifier at home to maintain optimal humidity levels in the air.
Side Effects
Side Effects
Common side effects of Salbair Neb 1.25 mg Transpules include dry mouth and cough.
Some patients may experience headaches or dizziness after using Salbair Neb 1.25 mg Transpules.
Nausea and gastrointestinal disturbances can occur but are usually mild.
In rare cases, Salbair Neb 1.25 mg Transpules may cause wheezing or bronchospasm immediately after administration.
If severe side effects occur, such as difficulty breathing or swelling of the face, seek medical attention promptly.
Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
Precautions & Warnings
Patients with a known allergy to Levosalbutamol or Ipratropium should avoid using Salbair Neb 1.25 mg Transpules.
Caution is advised in individuals with pre-existing heart conditions or hypertension.
Pregnant or breastfeeding women should consult their doctor before using Salbair Neb 1.25 mg Transpules.
Avoid alcohol consumption while using this medication as it may exacerbate side effects.
Patients should inform their doctor about all medications they are currently taking to avoid potential interactions.
Regular monitoring of blood potassium levels may be necessary during treatment with Salbair Neb 1.25 mg Transpules.
1. What conditions does Salbair Neb 1.25 mg Transpules treat?
Salbair Neb 1.25 mg Transpules is primarily used for managing chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms such as breathlessness.
2. How should I use Salbair Neb 1.25 mg Transpules?
Salbair Neb 1.25 mg Transpules should be used with a nebulizer as prescribed by your healthcare provider, typically every 6 to 8 hours.
3. Are there any side effects associated with Salbair Neb 1.25 mg Transpules?
Common side effects include dry mouth, cough, headache, and dizziness; however, most side effects are mild and resolve on their own.
4. Can I use Salbair Neb 1.25 mg Transpules if I'm pregnant?
Pregnant women should consult their healthcare provider before using Salbair Neb 1.25 mg Transpules to ensure safety for both mother and baby.
5. What should I do if I miss a dose of Salbair Neb 1.25 mg Transpules?
If you miss a dose of Salbair Neb 1.25 mg Transpules, take it as soon as you remember unless it's almost time for your next dose; do not double up.
6. Is it safe to drink alcohol while using Salbair Neb 1.25 mg Transpules?
It is advisable to avoid alcohol while using Salbair Neb 1.25 mg Transpules as it may increase side effects.
7. How does Salbair Neb 1.25 mg Transpules work?
Salbair Neb 1.25 mg Transpules works by combining Levosalbutamol and Ipratropium, which relaxes airway muscles and widens air passages for easier breathing.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Store below 25°C, away from direct sunlight and moisture.
Do not freeze.
Keep out of reach of children.
Dispose of unused or expired transpules properly, as per pharmacy guidance[1][2].
SKU
193053
Country of Manufacture
India
Manufacturer Address
Lupin Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Store below 25°C, away from direct sunlight and moisture.
Do not freeze.
Keep out of reach of children.
Dispose of unused or expired transpules properly, as per pharmacy guidance[1][2].
Seller
Kogland Commerce Pvt Ltd (TN)
Salbair Neb 1.25 mg Transpules is a specialized inhalation therapy designed for patients suffering from chronic obstructive pulmonary disease (COPD). This formulation combines two active ingredients: Levosalbutamol and Ipratropium, which work synergistically to provide effective relief from respiratory distress. Salbair Neb 1.25 mg Transpules is classified as a bronchodilator and anticholinergic medication, making it a vital option in the therapeutic category of respiratory treatments. The primary purpose of Salbair Neb 1.25 mg Transpules is to relax the muscles in the airways, thereby widening them and facilitating easier breathing for individuals with COPD. The unique composition of Salbair Neb 1.25 mg Transpules ensures that patients receive a controlled dose of medication directly to the lungs, maximizing its efficacy while minimizing systemic side effects. This targeted delivery system is crucial for managing chronic respiratory conditions effectively. Salbair Neb 1.25 mg Transpules is particularly beneficial for patients who experience frequent episodes of breathlessness and require a reliable solution to manage their symptoms. By utilizing Salbair Neb 1.25 mg Transpules, patients can achieve better control over their condition, leading to improved quality of life and enhanced daily functioning. The formulation is designed for inhalation only, ensuring that the active ingredients reach the site of action quickly and efficiently. With its dual-action mechanism, Salbair Neb 1.25 mg Transpules not only alleviates symptoms but also helps prevent exacerbations associated with COPD, making it an essential part of a comprehensive treatment plan. Overall, Salbair Neb 1.25 mg Transpules represents a significant advancement in the management of chronic respiratory diseases, providing patients with the relief they need to breathe easier and live better.
This formulation combines Levosalbutamol and Ipratropium for enhanced bronchodilation.
Salbair Neb 1.25 mg Transpules helps to relax airway muscles, making breathing easier.
Patients using Salbair Neb 1.25 mg Transpules may experience fewer exacerbations of their respiratory condition.
Salbair Neb 1.25 mg Transpules is suitable for long-term management of COPD symptoms.
This therapy can improve overall lung function in patients with chronic respiratory issues.
Salbair Neb 1.25 mg Transpules is designed for inhalation, ensuring rapid action at the site of need.
Using Salbair Neb 1.25 mg Transpules can lead to improved quality of life for COPD patients.
Salbair Neb 1.25 mg Transpules may reduce the frequency of rescue inhaler use.
This medication is beneficial for patients who struggle with breathlessness during daily activities.
Salbair Neb 1.25 mg Transpules can help manage nighttime symptoms associated with COPD.
Patients may find that Salbair Neb 1.25 mg Transpules aids in reducing coughing episodes.
Salbair Neb 1.25 mg Transpules supports better oxygenation by widening air passages.
This therapy can be integrated into a comprehensive COPD management plan.
Salbair Neb 1.25 mg Transpules is often recommended for use alongside other COPD medications.
How Salbair Neb 1.25 mg Transpules works
Salbair Neb 1.25 mg Transpules works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
Levosalbutamol: A selective beta-2 adrenergic agonist that relaxes bronchial smooth muscles, leading to bronchodilation.
Ipratropium: An anticholinergic agent that inhibits bronchoconstriction by blocking acetylcholine receptors in the airways.
Together, these ingredients help widen the airways, making it easier for air to flow in and out of the lungs.
The inhalation route allows for direct delivery to the lungs, enhancing the therapeutic effect while minimizing systemic absorption.
Salbair Neb 1.25 mg Transpules provides quick relief from acute symptoms and helps maintain long-term control over chronic respiratory conditions.
This combination therapy reduces airway inflammation and mucus secretion, further improving breathing efficiency.
How to use Salbair Neb 1.25 mg Transpules
Salbair Neb 1.25 mg Transpules should be administered using a nebulizer for optimal delivery.
The recommended dosage is typically one nebulization (2.5 ml) as prescribed by a healthcare professional.
Frequency of use may vary; generally, it is advised to use Salbair Neb 1.25 mg Transpules every 6 to 8 hours as needed.
Patients should follow their doctor's instructions regarding the timing and frequency of doses.
The duration of treatment with Salbair Neb 1.25 mg Transpules should be determined by a healthcare provider based on individual patient needs.
It is important to rinse the mouth after each use to prevent dryness and potential fungal infections.
Patients should not swallow the solution; it is intended solely for inhalation.
Initial doses should be taken under medical supervision to monitor for any adverse reactions.
Lifestyle Advice
Maintain good hydration by drinking plenty of fluids to help keep airways moist while using Salbair Neb 1.25 mg Transpules.
Avoid exposure to smoke and pollutants that can aggravate respiratory conditions.
Incorporate regular physical activity as tolerated to improve lung function and overall health.
Practice good oral hygiene to minimize dry mouth effects associated with Salbair Neb 1.25 mg Transpules.
Consider using a humidifier at home to maintain optimal humidity levels in the air.
Side Effects
Side Effects
Common side effects of Salbair Neb 1.25 mg Transpules include dry mouth and cough.
Some patients may experience headaches or dizziness after using Salbair Neb 1.25 mg Transpules.
Nausea and gastrointestinal disturbances can occur but are usually mild.
In rare cases, Salbair Neb 1.25 mg Transpules may cause wheezing or bronchospasm immediately after administration.
If severe side effects occur, such as difficulty breathing or swelling of the face, seek medical attention promptly.
Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
Precautions & Warnings
Patients with a known allergy to Levosalbutamol or Ipratropium should avoid using Salbair Neb 1.25 mg Transpules.
Caution is advised in individuals with pre-existing heart conditions or hypertension.
Pregnant or breastfeeding women should consult their doctor before using Salbair Neb 1.25 mg Transpules.
Avoid alcohol consumption while using this medication as it may exacerbate side effects.
Patients should inform their doctor about all medications they are currently taking to avoid potential interactions.
Regular monitoring of blood potassium levels may be necessary during treatment with Salbair Neb 1.25 mg Transpules.
1. What conditions does Salbair Neb 1.25 mg Transpules treat?
Salbair Neb 1.25 mg Transpules is primarily used for managing chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms such as breathlessness.
2. How should I use Salbair Neb 1.25 mg Transpules?
Salbair Neb 1.25 mg Transpules should be used with a nebulizer as prescribed by your healthcare provider, typically every 6 to 8 hours.
3. Are there any side effects associated with Salbair Neb 1.25 mg Transpules?
Common side effects include dry mouth, cough, headache, and dizziness; however, most side effects are mild and resolve on their own.
4. Can I use Salbair Neb 1.25 mg Transpules if I'm pregnant?
Pregnant women should consult their healthcare provider before using Salbair Neb 1.25 mg Transpules to ensure safety for both mother and baby.
5. What should I do if I miss a dose of Salbair Neb 1.25 mg Transpules?
If you miss a dose of Salbair Neb 1.25 mg Transpules, take it as soon as you remember unless it's almost time for your next dose; do not double up.
6. Is it safe to drink alcohol while using Salbair Neb 1.25 mg Transpules?
It is advisable to avoid alcohol while using Salbair Neb 1.25 mg Transpules as it may increase side effects.
7. How does Salbair Neb 1.25 mg Transpules work?
Salbair Neb 1.25 mg Transpules works by combining Levosalbutamol and Ipratropium, which relaxes airway muscles and widens air passages for easier breathing.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Store below 25°C, away from direct sunlight and moisture.
Do not freeze.
Keep out of reach of children.
Dispose of unused or expired transpules properly, as per pharmacy guidance[1][2].
SKU
193053
Country of Manufacture
India
Manufacturer Address
Lupin Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Store below 25°C, away from direct sunlight and moisture.
Do not freeze.
Keep out of reach of children.
Dispose of unused or expired transpules properly, as per pharmacy guidance[1][2].
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
